Rivaroxaban, Empagliflozin, Secukinumab Anticoagulants or Elven Council Members?
Ever looked at a drug name and thought, “That sounds like someone who’d wield a crystal staff”? You’re not alone. But behind the fantasy vibes lies a precise, regulated system one that’s surprisingly logical.
Let’s decode the magic.
Why Drug Names Sound So…Epic
Most generic drug names follow the International Nonproprietary Names (INN) system, developed by the WHO. These names aren’t random—they’re built from stems that reflect pharmacological class, mechanism, or target.
Think of stems as linguistic spells:
- –xaban → Direct Factor Xa inhibitors (e.g., Rivaroxaban)
- –gliflozin → SGLT2 inhibitors for diabetes (e.g., Empagliflozin)
- –umab → Human monoclonal antibodies (e.g., Secukinumab)
Each suffix tells you what the drug does even if it sounds like it belongs in Middle-earth.
Why This Matters for Professionals
- Predict pharmacology: You can often guess a drug’s class from its name.
- Spot lookalikes: Similar stems may signal similar effects or risks.
- Counsel with clarity: Explaining naming logic builds trust and reduces confusion.
Bonus: It makes you sound like you speak fluent “pharma.”
Drug names may sound mythical, but they’re built on science, structure, and global consensus. So next time you hear “Empagliflozin,” don’t picture a wizard picture a sodium-glucose co-transporter inhibitor doing its job.
Share something you found interesting !
MBH/PS